AR020016A2 - Compuestos derivados de la eritromicina, composiciones que los contienen, uso de los mismos para preparar un medicamento - Google Patents
Compuestos derivados de la eritromicina, composiciones que los contienen, uso de los mismos para preparar un medicamentoInfo
- Publication number
- AR020016A2 AR020016A2 ARP990106085A ARP990106085A AR020016A2 AR 020016 A2 AR020016 A2 AR 020016A2 AR P990106085 A ARP990106085 A AR P990106085A AR P990106085 A ARP990106085 A AR P990106085A AR 020016 A2 AR020016 A2 AR 020016A2
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- groups
- halogen atoms
- group
- substituted
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 2
- 229960003276 erythromycin Drugs 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 125000005843 halogen group Chemical group 0.000 abstract 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 2
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 abstract 1
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Un compuesto de la formula (1) o una sal farmacéuticamente aceptable de los mismos, en la que: R es un grupo alquilo C3-8 ramificado en alfa, alquenilo,alquinilo, alcoxialquilo o alquiltioalquilo, cualquiera de los cuales pueden estar opcionalmente sustituidos con uno o más grupos hidroxilo; un grupocicloalquilalquilo C5-8 en el que el grupo alquilo es un grupo alquilo C2-5 ramificado en alfa; un grupo cicloalquilo C3-8 o cicloalquenilo C5-8, cualquiera delos cuales puede estar opcionalmente sustituidos con grupos metilo, o uno o más hidroxilo, o uno o más grupos alquilo C1-4 o átomos de halogeno; o un anilloheterocíclico de 3 a 6 eslabones que contiene oxígeno o azufre que puede estar saturado o total o parcialmente insaturado y que puedeestar opcionalmentesustituido con uno o más grupos alquilo C1-4, o átomos de halogeno; o R es fenilo que puede estar opcionalmente sustituido con al menos un sustituyenteseleccionado entre los grupos alquilo C1-4, alcoxi C1-4, alquiltio C1-4, átomosde halogeno, grupos hidroxilo, trifluorometilo y ciano; o R puede tener laformula (2) como se muestra a continuacion, en la que X1 es O, S, -CH2-, a, b, c, y d se seleccionan independientemente cada uno de ellos entre un numeroentero que oscila entre0 y 2 y a + b + c + d menor igual a 5; o R es CH2R24, donde R24 es H, alquilo C1-8, alquenilo C2-8, alquinilo C2-8, alcoxialquilo oalquiltioalquilo que contiene de 1 a 6 átomos de carbono en cada grupo alquilo o alcoxi, donde cualquiera de dichos grupo alquilo, alcoxi, alquenilo oalquinilo pueden estar sustituidos por uno o más grupos hidroxilo o por uno o más átomos de halogeno; o un cicloalquilo C3-8 o cicloalquenilo C5-8, pudiendoestar cualquiera de ellos opcionalmente sustituido por metiloo uno o más grupos alquilo C1-4 o átomos de halogeno; o un heterociclo de 3 a 6 miembros quecontiene oxígeno o azufre, que puede estar saturado o total o parcialmente insaturado y que opcionalmente puede estar sustituido por uno o más grupos alquiloC1-4 o átomos de halogeno; o un grupo de la formula SR23, donde R23 es alquilo C1-8,
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7035898P | 1998-01-02 | 1998-01-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR020016A2 true AR020016A2 (es) | 2002-03-27 |
Family
ID=22094819
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980106716A AR012764A1 (es) | 1998-01-02 | 1998-12-29 | Compuestos derivados de la eritromicina, composiciones que los contienen, usos y procedimientos para prepararlos. |
| ARP990106085A AR020016A2 (es) | 1998-01-02 | 1999-11-30 | Compuestos derivados de la eritromicina, composiciones que los contienen, uso de los mismos para preparar un medicamento |
| ARP990106082A AR019788A2 (es) | 1998-01-02 | 1999-11-30 | Compuestos derivados de la eritromicina, composiciones que los contienen, uso y procedimientos para prepararlos |
| ARP990106083A AR019789A2 (es) | 1998-01-02 | 1999-11-30 | Compuestos derivados de la eritromicina, composiciones que los contienen, uso de los mismos para preparar un medicamento |
| ARP990106084A AR019790A2 (es) | 1998-01-02 | 1999-11-30 | Compuestos derivados de la eritromicina, composiciones que los contienen. uso para preparar un medicamento |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980106716A AR012764A1 (es) | 1998-01-02 | 1998-12-29 | Compuestos derivados de la eritromicina, composiciones que los contienen, usos y procedimientos para prepararlos. |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990106082A AR019788A2 (es) | 1998-01-02 | 1999-11-30 | Compuestos derivados de la eritromicina, composiciones que los contienen, uso y procedimientos para prepararlos |
| ARP990106083A AR019789A2 (es) | 1998-01-02 | 1999-11-30 | Compuestos derivados de la eritromicina, composiciones que los contienen, uso de los mismos para preparar un medicamento |
| ARP990106084A AR019790A2 (es) | 1998-01-02 | 1999-11-30 | Compuestos derivados de la eritromicina, composiciones que los contienen. uso para preparar un medicamento |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6825171B2 (es) |
| EP (2) | EP1642901B1 (es) |
| JP (1) | JP2002500231A (es) |
| KR (1) | KR20010033822A (es) |
| CN (1) | CN1285841A (es) |
| AP (1) | AP1060A (es) |
| AR (5) | AR012764A1 (es) |
| AT (1) | ATE377018T1 (es) |
| AU (1) | AU759019B2 (es) |
| BG (1) | BG104640A (es) |
| BR (1) | BR9812992A (es) |
| CA (1) | CA2317131C (es) |
| CO (1) | CO4970773A1 (es) |
| CZ (1) | CZ20002456A3 (es) |
| DE (1) | DE69838651T9 (es) |
| DZ (1) | DZ2699A1 (es) |
| EA (1) | EA200000600A1 (es) |
| ES (1) | ES2294641T3 (es) |
| GT (1) | GT199800207A (es) |
| HR (1) | HRP20000444A2 (es) |
| HU (1) | HUP0100566A3 (es) |
| IL (1) | IL136721A0 (es) |
| IS (1) | IS5527A (es) |
| MA (1) | MA26588A1 (es) |
| NO (1) | NO20003346L (es) |
| NZ (1) | NZ504987A (es) |
| OA (1) | OA11440A (es) |
| PA (1) | PA8465901A1 (es) |
| PE (1) | PE20000119A1 (es) |
| PL (1) | PL341647A1 (es) |
| SK (1) | SK9772000A3 (es) |
| TN (1) | TNSN98236A1 (es) |
| UY (2) | UY25331A1 (es) |
| WO (1) | WO1999035157A1 (es) |
| YU (1) | YU40900A (es) |
| ZA (1) | ZA9811940B (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP9801420A0 (en) | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| AP1060A (en) | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
| GB9814006D0 (en) | 1998-06-29 | 1998-08-26 | Biotica Tech Ltd | Polyketides and their synthesis |
| EP1749832A3 (en) * | 1998-12-10 | 2008-03-26 | Pfizer Products Incorporated | Carbamate and carbazate ketolide antibiotics |
| EP1298138B1 (en) * | 1998-12-10 | 2006-11-02 | Pfizer Products Inc. | Carbamate and Carbazate Ketolide Antibiotics |
| DE69933897T2 (de) | 1998-12-10 | 2007-03-15 | Pfizer Products Inc., Groton | Carbamat- und Carbazatketolid-Antibiotika |
| EP1754700A3 (en) | 1999-01-27 | 2007-05-09 | Kosan Biosciences, Inc. | Synthesis of oligoketides |
| CA2359708C (en) | 1999-01-27 | 2005-10-25 | Pfizer Products Inc. | Ketolide antibiotics |
| CA2370743A1 (en) | 1999-04-16 | 2000-10-26 | Dennis Hlasta | Ketolide antibacterials |
| US6514944B2 (en) | 1999-04-16 | 2003-02-04 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
| ATE340183T1 (de) | 1999-04-16 | 2006-10-15 | Kosan Biosciences Inc | Antiinfektiöse makrolidderivate |
| US6939861B2 (en) | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
| US6590083B1 (en) * | 1999-04-16 | 2003-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
| US6451768B1 (en) | 1999-04-16 | 2002-09-17 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
| HUP0201516A3 (en) * | 1999-05-24 | 2003-03-28 | Pfizer Prod Inc | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them |
| ID27331A (id) * | 1999-09-29 | 2001-03-29 | Pfizer Prod Inc | Pembuatan antibiotik-antibiotik ketolida karbamat |
| EP1114826A3 (en) * | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Novel antibacterial and prokinetic macrolides |
| WO2001060833A2 (en) | 2000-02-18 | 2001-08-23 | Kosan Biosciences, Inc. | Motilide compounds |
| US20020115621A1 (en) | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
| US6472372B1 (en) | 2000-12-06 | 2002-10-29 | Ortho-Mcneil Pharmaceuticals, Inc. | 6-O-Carbamoyl ketolide antibacterials |
| CA2451391A1 (en) | 2001-07-03 | 2003-01-16 | Chiron Corporation | C12 modified erythromycin macrolides and ketolides having antibacterial activity |
| WO2003024986A1 (en) | 2001-09-17 | 2003-03-27 | Ortho-Mcneil Pharmaceutical, Inc. | 6-o-carbamate-11,12-lacto-ketolide antimicrobials |
| AU2002346475A1 (en) | 2001-12-05 | 2003-06-23 | Ortho-Mcneil Pharmaceutical, Inc. | 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials |
| CN1671726A (zh) | 2002-05-31 | 2005-09-21 | 詹森药业有限公司 | 3－脱克拉定糖基－6－o－氨基甲酰基和6－o－烷氧基羰基大环内酯抗菌药 |
| US7163924B2 (en) | 2003-04-25 | 2007-01-16 | Chiron Corporation | Ketolide derivatives |
| UA85937C2 (uk) | 2004-12-21 | 2009-03-10 | Пфайзер Продактс Інк. | Макроліди |
| WO2007144876A1 (en) | 2006-06-12 | 2007-12-21 | Ramot At Tel-Aviv University Ltd. | Methods for treating cancer |
| KR20150098675A (ko) | 2012-12-24 | 2015-08-28 | 라모트 앳 텔-아비브 유니버시티 리미티드 | 넌센스 돌연변이로부터 생긴 유전적 질환을 치료하기 위한 물질 및 이를 확인하는 방법 |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US156027A (en) * | 1874-10-20 | Improvement in loom-shuttles | ||
| US77302A (en) * | 1868-04-28 | mat son | ||
| US100518A (en) * | 1870-03-08 | Roland s | ||
| US61856A (en) * | 1867-02-05 | Enos s | ||
| US61857A (en) * | 1867-02-05 | Improvement in top-drivers or spinners | ||
| US4331803A (en) * | 1980-06-04 | 1982-05-25 | Taisho Pharmaceutical Co., Ltd. | Novel erythromycin compounds |
| SI8110592A8 (en) | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
| AU1142383A (en) | 1982-04-26 | 1983-11-03 | Shakas, P.V. | Infant transitional sensory system |
| US4474768A (en) | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| US4998097A (en) | 1983-07-11 | 1991-03-05 | Square D Company | Mechanically operated pressure switch having solid state components |
| JPS61103890A (ja) * | 1984-10-26 | 1986-05-22 | Taisho Pharmaceut Co Ltd | ６−０−メチルエリスロマイシンａ誘導体 |
| US4585759A (en) * | 1985-01-22 | 1986-04-29 | Pfizer Inc. | Antibacterial derivatives of a neutral macrolide |
| JPS61229895A (ja) * | 1985-04-03 | 1986-10-14 | Nippon Zeon Co Ltd | 保護化デス−ｎ−メチルエリスロマイシン誘導体 |
| ES8800986A1 (es) | 1985-07-27 | 1987-12-01 | Pfizer | Un procedimiento para la produccion de un nuevo derivado de avermectina |
| US4672056A (en) * | 1985-11-12 | 1987-06-09 | Abbott Laboratories | Erythromycin A derivatives and method of use |
| JPH0633312B2 (ja) | 1986-05-02 | 1994-05-02 | 大正製薬株式会社 | １４−ハイドロキシエリスロマイシン誘導体およびその製造方法 |
| HU198913B (en) * | 1987-09-03 | 1989-12-28 | Pliva Pharm & Chem Works | Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components |
| GB8726730D0 (en) | 1987-11-14 | 1987-12-16 | Pfizer Ltd | Antiparasitic agents |
| GB8815967D0 (en) | 1988-07-05 | 1988-08-10 | Pfizer Ltd | Antiparasitic agents |
| US4934897A (en) | 1989-02-23 | 1990-06-19 | J. I. Case Company | Pipe-moving apparatus |
| US5141926A (en) | 1990-04-18 | 1992-08-25 | Abbott Laboratories | Erythromycin derivatives |
| IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
| US6060234A (en) * | 1991-01-17 | 2000-05-09 | Abbott Laboratories | Polyketide derivatives and recombinant methods for making same |
| WO1993013663A1 (en) | 1992-01-17 | 1993-07-22 | Abbott Laboratories | Method of directing biosynthesis of specific polyketides |
| US5824513A (en) * | 1991-01-17 | 1998-10-20 | Abbott Laboratories | Recombinant DNA method for producing erythromycin analogs |
| JP3286941B2 (ja) * | 1991-07-09 | 2002-05-27 | 株式会社日立製作所 | ダイヤモンド研削砥石のツルーイング法 |
| US5523399A (en) * | 1991-12-27 | 1996-06-04 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide derivatives |
| FR2691464B1 (fr) | 1992-05-21 | 1995-06-02 | Roussel Uclaf | Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments. |
| FR2692579B1 (fr) * | 1992-06-19 | 1995-06-02 | Roussel Uclaf | Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments. |
| US5332807A (en) * | 1993-04-14 | 1994-07-26 | Merck & Co., Inc. | Process of producing 8A- and 9A-azalide antibiotics |
| US6066721A (en) * | 1995-07-06 | 2000-05-23 | Stanford University | Method to produce novel polyketides |
| US5441939A (en) * | 1994-03-04 | 1995-08-15 | Pfizer Inc. | 3"-desmethoxy derivatives of erythromycin and azithromycin |
| FR2718450B1 (fr) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| US5486697A (en) | 1994-11-14 | 1996-01-23 | California Institute Of Technology | Array of micro-machined mass energy micro-filters for charged particles |
| FR2732023B1 (fr) * | 1995-03-22 | 1997-04-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| FR2732684B1 (fr) * | 1995-04-06 | 1997-04-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| US5801032A (en) | 1995-08-03 | 1998-09-01 | Abbott Laboratories | Vectors and process for producing high purity 6,12-dideoxyerythromycin A by fermentation |
| WO1997008266A1 (en) | 1995-08-22 | 1997-03-06 | Mobil Oil Corporation | Visbreaking process using plastics as co-feed |
| ATE259823T1 (de) | 1995-11-08 | 2004-03-15 | Abbott Lab | Tricyclische erythromycinderivate |
| US6077943A (en) * | 1996-03-01 | 2000-06-20 | Takeda Chemical Industries, Ltd. | Method of producing erythromycin derivative |
| US5719272A (en) * | 1996-04-02 | 1998-02-17 | Abbott Laboratories | 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives |
| US5750510A (en) * | 1997-04-04 | 1998-05-12 | Abbott Laboratories | 3-descladinose-2,3-anhydroerythromycin derivatives |
| ES2244001T3 (es) | 1996-07-05 | 2005-12-01 | Biotica Technology Limited | Eritromicinas y procedimiento para su preparacion. |
| US6271255B1 (en) * | 1996-07-05 | 2001-08-07 | Biotica Technology Limited | Erythromycins and process for their preparation |
| DE69733422T2 (de) * | 1996-09-04 | 2006-05-04 | Abbott Laboratories, Abbott Park | 6-0-substituierte ketoliden mit antibakteriellen wirkung |
| FR2754821B1 (fr) | 1996-10-23 | 2003-04-04 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| NL1006540C2 (nl) | 1997-07-10 | 1999-01-15 | Skf Ind Trading & Dev | Elektrische actuator met regelsensor, alsmede schijfrem omvattende een dergelijke actuator. |
| JPH11167611A (ja) | 1997-08-28 | 1999-06-22 | Supersensor Pty Ltd | 電子認証システムのための読取装置 |
| US6034069A (en) * | 1997-09-30 | 2000-03-07 | Abbott Laboratories | 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity |
| AP1060A (en) | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
| AP9801420A0 (en) | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| ATE275151T1 (de) * | 1998-03-03 | 2004-09-15 | Pfizer Prod Inc | 3,6-ketal-makrolidantibiotika |
| US5975370A (en) * | 1998-03-16 | 1999-11-02 | Owens-Illinois Closure Inc. | Tamper-evident plunger-hold-down attachment for pump dispenser |
| US6043227A (en) * | 1998-08-19 | 2000-03-28 | Pfizer Inc. | C11 carbamates of macrolide antibacterials |
| US6100240A (en) * | 1998-10-09 | 2000-08-08 | Pfizer Inc | Macrolide derivatives |
| US6262030B1 (en) * | 1998-11-03 | 2001-07-17 | Pfizer Inc. | Erythromycin derivatives |
| CA2359708C (en) | 1999-01-27 | 2005-10-25 | Pfizer Products Inc. | Ketolide antibiotics |
| WO2000046404A1 (en) | 1999-02-05 | 2000-08-10 | Wrair Walter Reed Army Institute Of Research | Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
| CA2370743A1 (en) * | 1999-04-16 | 2000-10-26 | Dennis Hlasta | Ketolide antibacterials |
| ATE340183T1 (de) * | 1999-04-16 | 2006-10-15 | Kosan Biosciences Inc | Antiinfektiöse makrolidderivate |
| US20020077302A1 (en) | 1999-04-23 | 2002-06-20 | Yong-Jin Wu | Tricyclic erythromycin derivatives |
| US20020061857A1 (en) | 1999-04-23 | 2002-05-23 | Yong-Jin Wu | 9-amino-3-oxo erythromycin derivatives |
| HUP0201516A3 (en) | 1999-05-24 | 2003-03-28 | Pfizer Prod Inc | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them |
| EP1101769A3 (en) * | 1999-11-18 | 2001-10-24 | Pfizer Products Inc. | Nitrogen containing erythromycin derivatives |
| US20020061856A1 (en) | 2000-04-24 | 2002-05-23 | Yong-Jin Wu | Novel tricyclic erythromycin derivatives |
| JP2005050903A (ja) | 2003-07-30 | 2005-02-24 | Toshiba Corp | 半導体装置およびその製造方法 |
-
1998
- 1998-12-17 AP APAP/P/1998/001421A patent/AP1060A/en active
- 1998-12-21 PL PL98341647A patent/PL341647A1/xx unknown
- 1998-12-21 HR HR20000444A patent/HRP20000444A2/hr not_active Application Discontinuation
- 1998-12-21 EP EP05106836A patent/EP1642901B1/en not_active Expired - Lifetime
- 1998-12-21 HU HU0100566A patent/HUP0100566A3/hu unknown
- 1998-12-21 NZ NZ504987A patent/NZ504987A/xx unknown
- 1998-12-21 WO PCT/IB1998/002100 patent/WO1999035157A1/en not_active Ceased
- 1998-12-21 IL IL13672198A patent/IL136721A0/xx unknown
- 1998-12-21 CZ CZ20002456A patent/CZ20002456A3/cs unknown
- 1998-12-21 EP EP98959099A patent/EP1044208A1/en not_active Withdrawn
- 1998-12-21 SK SK977-2000A patent/SK9772000A3/sk unknown
- 1998-12-21 CN CN98812832A patent/CN1285841A/zh active Pending
- 1998-12-21 ES ES05106836T patent/ES2294641T3/es not_active Expired - Lifetime
- 1998-12-21 AU AU15015/99A patent/AU759019B2/en not_active Ceased
- 1998-12-21 YU YU40900A patent/YU40900A/sh unknown
- 1998-12-21 CA CA002317131A patent/CA2317131C/en not_active Expired - Fee Related
- 1998-12-21 EA EA200000600A patent/EA200000600A1/ru unknown
- 1998-12-21 AT AT05106836T patent/ATE377018T1/de not_active IP Right Cessation
- 1998-12-21 DE DE69838651T patent/DE69838651T9/de not_active Expired - Fee Related
- 1998-12-21 BR BR9812992-9A patent/BR9812992A/pt not_active Application Discontinuation
- 1998-12-21 KR KR1020007007378A patent/KR20010033822A/ko not_active Ceased
- 1998-12-21 JP JP2000527553A patent/JP2002500231A/ja active Pending
- 1998-12-28 PE PE1998001285A patent/PE20000119A1/es not_active Application Discontinuation
- 1998-12-29 AR ARP980106716A patent/AR012764A1/es not_active Application Discontinuation
- 1998-12-30 MA MA25408A patent/MA26588A1/fr unknown
- 1998-12-30 ZA ZA9811940A patent/ZA9811940B/xx unknown
- 1998-12-30 CO CO98077582A patent/CO4970773A1/es unknown
- 1998-12-30 PA PA19988465901A patent/PA8465901A1/es unknown
- 1998-12-30 UY UY25331A patent/UY25331A1/es not_active Application Discontinuation
- 1998-12-30 TN TNTNSN98236A patent/TNSN98236A1/fr unknown
- 1998-12-30 GT GT199800207A patent/GT199800207A/es unknown
- 1998-12-30 DZ DZ980309A patent/DZ2699A1/xx active
-
1999
- 1999-06-25 UY UY25587A patent/UY25587A1/es not_active Application Discontinuation
- 1999-11-30 AR ARP990106085A patent/AR020016A2/es not_active Application Discontinuation
- 1999-11-30 AR ARP990106082A patent/AR019788A2/es not_active Application Discontinuation
- 1999-11-30 AR ARP990106083A patent/AR019789A2/es not_active Application Discontinuation
- 1999-11-30 AR ARP990106084A patent/AR019790A2/es not_active Application Discontinuation
-
2000
- 2000-06-09 IS IS5527A patent/IS5527A/is unknown
- 2000-06-27 NO NO20003346A patent/NO20003346L/no unknown
- 2000-06-30 OA OA1200000194A patent/OA11440A/en unknown
- 2000-07-27 BG BG104640A patent/BG104640A/xx unknown
-
2003
- 2003-04-08 US US10/409,016 patent/US6825171B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR020016A2 (es) | Compuestos derivados de la eritromicina, composiciones que los contienen, uso de los mismos para preparar un medicamento | |
| AR020851A2 (es) | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos | |
| ES2061204T3 (es) | Nuevos derivados de la amino-piperidina, de la amino-pirrolidina y de la amino-perhidroacepina, procedimientos de preparacion y composiciones farmaceuticas que los contienen. | |
| BR0111754A (pt) | Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica | |
| DE69232854D1 (de) | Bizyklische fibrinogenantagonisten | |
| ES8202334A1 (es) | Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina | |
| AR034858A1 (es) | Compuestos elevadores de abca-1,composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento | |
| ES2076009T3 (es) | Nuevos inhibidores de n-miristoil-transferasa, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| AR020165A1 (es) | Derivados de pirimidinas sustituidas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y el uso de los mismos para la preparacion de medicamentos | |
| AR012878A1 (es) | Un compuesto derivado de 5'-desoxicitidina, su uso, un proceso para fabricarlo, composiciones farmaceuticas que lo comprende, y un kit que comprende dicha composicion. | |
| MX9202438A (es) | Esteroides 3-carboxi insaturados substituidos en la posicion 17 beta, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| AR012436A1 (es) | Compuestos de 4-aminopirido[2,3-d]pirimidina 5,7-disustituidos, composicion farmaceutica que los comprende, el uso de los mismos para lamanufactura de medicamentos, un procedimiento para su preparacion. | |
| PE20021018A1 (es) | DERIVADOS DE ß - CARBOLINA | |
| DE69423528D1 (de) | Arzneimittel enthaltend Argatroban Analoga | |
| AR045669A1 (es) | Derivados de amida que contienen silicio, con actividad microbicida | |
| DK455285A (da) | 2-pyridin-thiolderivater | |
| KR970704723A (ko) | 항염증제로서 유용한 디히드로벤조푸란 및 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents) | |
| KR890701584A (ko) | 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물 | |
| SE7412163L (es) | ||
| MX9203068A (es) | Compuestos activirales oralmente activos. | |
| ES2094132T3 (es) | Uso de derivados de xantina contra la ulcera peptica. | |
| KR910004628A (ko) | 피리도[2,3-b][1,5]벤즈옥사제핀 (및 티아제핀)-5(6H)-온 및-티온 및 HIV 감염의 예방 또는 치료에 있어서의 그들의 용도 | |
| AR011137A1 (es) | Derivados de 4-aminoetoxiindazol, su uso para la preparacion de un medicamento y composiciones farmaceuticas que los contienen | |
| KR920002613A (ko) | 이환성 함유 황화합물 | |
| EP0273357A3 (en) | Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |